Obesity is a growing health concern that involves complex factors beyond just energy intake and expenditure. Clinical trials evaluate the safety and efficacy of new and existing weight-loss medication and different lifestyle approaches to promote weight loss and management, prevent and treat comorbidities, such as type 2 diabetes, and tackle the reasons behind obesity.
As overweight and obesity rates continue to rise in modern societies, there is an increased medical attention to address their impact. Obesity lies at the core of our expertise. Our research team has extensive scientific and clinical experience in treating patients with obesity and dealing with excess weight and existing comorbidities. We conduct clinical trials with a holistic approach to treating and preventing obesity and its complications, while also welcoming healthy volunteers to participate.
In our trials, we have focused, for example, on diabetes patients using oral medications and insulin therapy, as well as patients with metabolic dysfunction-associated liver disease. Our holistic approach is further supported by our ability to perform a wide range of examinations, including body imaging and DXA scanning.
We are here to advance your therapeutic breakthroughs with extensive scientific and clinical experience, always adhering to Good Clinical Practice (GCP).
Contact usClinical trials are our core business and top priority—and we ensure they are always supported with dedicated, expert resources. Please see below for our ongoing and previous clinical trials.
A large international multicenter study of a novel weight loss medication for the prevention of cardiovascular disease in individuals with excess body weight and established cardiovascular disease
A large international multicenter study of a novel weight loss medication in individuals with excess body weight
A large international multicenter study of a novel inflammation-lowering medication on heart failure outcomes in individuals with heart failure and low-grade inflammation
A large international multicenter study of a novel weight loss medication in individuals with excess body weight and type 2 diabetes
A large international multicenter study of a novel weight loss medication in individuals with excess body weight but without diabetes
A large international multicenter study of a novel cholesterol-lowering medication for the prevention of cardiovascular events in individuals with established cardiovascular disease
A large international multicenter study of two weight loss medications in individuals with excess body weight
A large international multicenter study of a weight loss medication and long-acting insulin on glucose management in individuals with type 2 diabetes
A large international multicenter study of a novel anticoagulant for the prevention of stroke in individuals with atrial fibrillation
A large international multicenter study of a weight loss medication on the incidence of cardiovascular disease in individuals with excess body weight but without diabetes
A large international multicenter study of a novel cholesterol-lowering medication on the incidence of cardiovascular disease in individuals at elevated risk
A large international multicenter study of a cholesterol-lowering medication on the incidence of cardiovascular disease in individuals at elevated risk